Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000812295-02-000104
Filing Date
2002-02-13
Accepted
2002-02-13 00:00:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 tevaphar.txt SC 13G 9653
  Complete submission text file 0000812295-02-000104.txt   11617
Mailing Address 100 FILLMORE STREET SUITE 300 DENVER CO 80206-4923
Business Address 100 FILLMORE STREET SUITE 300 DENVER CO 80206-4923 3033333863
JANUS CAPITAL CORP (Filed by) CIK: 0000812295 (see all company filings)

State of Incorp.: CO | Fiscal Year End: 1231
SIC: 0000

Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131
TEVA PHARMACEUTICAL INDUSTRIES LTD (Subject) CIK: 0000818686 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-39159 | Film No.: 02539932
SIC: 2834 Pharmaceutical Preparations